KAPA

Kairos Pharma, Ltd.
KAPA

Overview Fund Activity

8 hedge funds and large institutions have $1.46M invested in Kairos Pharma, Ltd. in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
Armistice Capital
New York
$1.31M
2
SRL
Scientech Research LLC
New Jersey
$45.1K
3
ACA
Aptus Capital Advisors
Alabama
$41.5K
4
SFG
SevenBridge Financial Group
Pennsylvania
$28.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
$19.1K

Top Sellers

1
UB
UMB Bank
Missouri
$0
2
VF
Virtu Financial
New York
$0
3
UBS Group
UBS Group
Switzerland
$2.61K
Name Holding Trade Value Shares
Change 		Shares
Change %
AC
1
Armistice Capital
New York
$1.31M +$1.31M +1,404,000 New
SRL
2
Scientech Research LLC
New Jersey
$45.1K +$45.1K +48,198 New
ACA
3
Aptus Capital Advisors
Alabama
$41.5K +$41.5K +44,286 New
SFG
4
SevenBridge Financial Group
Pennsylvania
$28.3K +$28.3K +44,286 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$19.1K +$19.1K +20,433 New
Citadel Advisors
6
Citadel Advisors
Florida
$12.4K +$2.12K +2,261 +21%
UBS Group
7
UBS Group
Switzerland
$2.61K -$7.54K -8,053 -74%
Bank of America
8
Bank of America
North Carolina
$20 +$8 +8 +62%
UB
9
UMB Bank
Missouri
– -$564K -371,115 Closed
VF
10
Virtu Financial
New York
– -$21K -13,656 Closed